CAS No.:54-47-7

TOXICITY DATA with REFERENCE：

Organism	Test Type	Route	Reported Dose (Normalized Dose)	Effect	Source
mammal (species unspecified)	LD50	oral	> 3gm/kg (3000mg/kg)		British Patent Document. Vol. #1172800,
mammal (species unspecified)	LD50	subcutaneous	550mg/kg (550mg/kg)		British Patent Document. Vol. #1172800,
mouse	LD50	intramuscular	1150mg/kg (1150mg/kg)	BEHAVIORAL: ANTIPSYCHOTIC	Pharmaceutical Chemistry Journal Vol. 15, Pg. 303, 1981.
mouse	LD50	intravenous	530mg/kg (530mg/kg)		Drugs in Japan Vol. 6, Pg. 643, 1982.
mouse	LD50	oral	4640mg/kg (4640mg/kg)		Drugs in Japan Vol. 6, Pg. 643, 1982.
mouse	LD50	subcutaneous	870mg/kg (870mg/kg)		Drugs in Japan Vol. 6, Pg. 643, 1982.
rat	LD50	oral	5900mg/kg (5900mg/kg)		Drugs in Japan Vol. 6, Pg. 643, 1982.
rat	LD50	subcutaneous	850mg/kg (850mg/kg)		Drugs in Japan Vol. 6, Pg. 643, 1982.

Consensus Reports：

Reported in EPA TSCA Inventory.

SAFETY PROFILE：

Moderately toxic subcutaneous, intravenous, and intramuscular routes. Mildly toxic by ingestion. Mutation data reported. When heated to decomposition it emits toxic fumes of NO_x and PO_x.
Safety Statements: 22-24/25 
S22: Do not breathe dust. 
S24/25: Avoid contact with skin and eyes.
WGK Germany: 3
F: 8-10-23

Standards and Recommendations：

 

Analytical Methods：